Partial N-terminal amino acid sequence of the anti-neoplastic urinary protein (ANUP) and the anti-tumour effect of the N-terminal nonapeptide of the unique cytokine present in human granulocytes

Cytokine

Volumn 8, Issue 1, 1996, Pages 1-5

  Ridge, Richard J ^a   Sloane, Nathan H ^b,c  

^a WOODS HOLE OCEANOGRAPHIC INSTITUTION   (United States)

^b UNIVERSITY OF MEMPHIS   (United States)

^c Anti tumor Research Products Inc   (United States)

Author keywords

Anti neoplastic; Cytokine; Urinary

Indexed keywords

ANTINEOPLASTIC AGENT; CYSTEINE; CYTOKINE; NONAPEPTIDE; SYNTHETIC PEPTIDE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DATA BASE; GRANULOCYTE; HUMAN; HUMAN CELL; MALE; MEMBRANE FILTER; PRIORITY JOURNAL; PROTEIN PURIFICATION; SEQUENCE HOMOLOGY;

EID: 0029944864     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0001     Document Type: Article

References (16)

1. Sloane NH, Lynn WR, MacLeod RM, Hade EPK, Pottathil R, Kyriazis AP (1986) Isolation of an antineoplastic protein fraction from human urine. Biochem J 234:355-362.
2. Pottathil R, Aggarwal S, Davis LH, Bucovaz ET, Sloane NH (1990) Evidence that the antineoplastic urinary protein (ANUP) is present in human granulocytes. Cancer Therapy and Control 1:193-198.
3. Struve WG, Crocker DW, Sloane NH (1990) Evidence for the cellular internalization of the antineoplastic urinary protein (ANUP). Cancer Therapy and Control 1:225-230.
4. Reichelt KL, Elgjo K, Edminson PD (1987) Isolation and structure of an epidermal mitosis inhibiting pentapeptide. Biochem Biophys Res Comm 146:1493-1501.
5. Matsudaira P (1987) Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes. J Biol Chem 262:10035-10038.
6. Kull RC Jr, Cuatrecasas P (1983) Estimation of cell number of neutral red content. Appl Biochem Biotech 8:97-103.
7. Laemmli UK (1970) Cleavage of structural proteins during assembly of the head of the bacteriophage T4. Nature (London) 227:680-685.
8. Ihle JN, Pepersack L, Rebar L (1981) Regulation of T cell differentiation: In vitro induction of 20a-hydroxysteroid dehydrogenase in splenic lymphocytes from athymic mice by a unique lymphokine. J Immunol 126:2184-2189.
9. Ihle JN, Keller J, Oroszlan S, Henderson LE, Copeland TD, Fitch F, Prystowsky MB, Goldwasser E, Schrader JW, Palaszynski E, Dy M, Lebel B (1983) Biologic properties of homogeneous Interleukin 3: I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, P cell-stimulating factor activity, colony-stimulating factor activity and histamine-producing cell-stimulating factor activity. J Immunol 131:282-287.
10. Schrader JW (1991) Interleukin 3. Cytokine Handbook. A. Thompson (ed.), Academic Press, pp. 101-118.
11. Isakson PC, Pure E, Vitetta ES, Krammer PH (1982) T cell-derived B cell differentiation factor(s) - Effect on the isotype switch of murine B cells. J Exp Med 155:734-748.
12. Tepper RI, Pattengale PK and Leder P (1989) Murine Interleukin-4 displays potent antitumor activity in vivo. Cell 57:503-512.
13. Paul WE (1991) Interleukin 4: A prototypic immunoregulatory lymphokine. Blood 77:1859-1870.
14. White A, Hander P, Smith EL. (1973) Principles of Biochemistry. McGraw-Hill, New York, New York, Fifth Ed. p. 939.
15. White A, Hander P, Smith EL. (1973) Principles of Biochemistry. McGraw-Hill, New York, New York, Fifth Ed. p. 1113.
16. Sloane NH (1990) Unpublished data.